Adtalem Global Education (NYSE:CVSA) SVP Douglas Beck Sells 9,615 Shares

Posted by Brian Himes on May 12th, 2026

Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) SVP Douglas Beck sold 9,615 shares of Adtalem Global Education stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $127.03, for a total transaction of $1,221,393.45. Following the sale, the senior vice president owned 38,159 shares of the company’s stock, valued at approximately $4,847,337.77. The trade was a 20.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of CVSA stock traded down $1.96 during midday trading on Tuesday, reaching $128.28. 239,676 shares of the company traded hands, compared to its average volume of 392,864. The business’s 50 day moving average price is $111.84. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. The stock has a market cap of $4.37 billion, a price-to-earnings ratio of 19.98, a PEG ratio of 1.11 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The company had revenue of $487.03 million during the quarter. During the same quarter in the previous year, the business posted $1.92 earnings per share. Adtalem Global Education’s revenue was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, research analysts anticipate that Adtalem Global Education Inc. will post 8.05 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CVSA shares. Barrington Research reissued an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Friday, April 17th. Weiss Ratings started coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They set a “hold (c+)” rating for the company. Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday. Truist Financial raised their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Get Our Latest Stock Analysis on CVSA

About Adtalem Global Education

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.